160 related articles for article (PubMed ID: 38437875)
1. The lysosomal β-glucocerebrosidase strikes mitochondria: implications for Parkinson's therapeutics.
Rubilar JC; Outeiro TF; Klein AD
Brain; 2024 Mar; ():. PubMed ID: 38437875
[TBL] [Abstract][Full Text] [Related]
2. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
[TBL] [Abstract][Full Text] [Related]
3. A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy.
Cosden M; Jinn S; Yao L; Gretzula CA; Kandebo M; Toolan D; Hatcher NG; Ma L; Lemaire W; Adam GC; Burlein C; Minnick C; Flick R; Watt ML; Mulhearn J; Fraley M; Drolet RE; Marcus JN; Smith SM
Neurobiol Dis; 2021 Nov; 159():105507. PubMed ID: 34509608
[TBL] [Abstract][Full Text] [Related]
4. Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons.
Rocha EM; Smith GA; Park E; Cao H; Brown E; Hayes MA; Beagan J; McLean JR; Izen SC; Perez-Torres E; Hallett PJ; Isacson O
Neurobiol Dis; 2015 Oct; 82():495-503. PubMed ID: 26392287
[TBL] [Abstract][Full Text] [Related]
5. TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease.
Seo BA; Kim D; Hwang H; Kim MS; Ma SX; Kwon SH; Kweon SH; Wang H; Yoo JM; Choi S; Kwon SH; Kang SU; Kam TI; Kim K; Karuppagounder SS; Kang BG; Lee S; Park H; Kim S; Yan W; Li YS; Kuo SH; Redding-Ochoa J; Pletnikova O; Troncoso JC; Lee G; Mao X; Dawson VL; Dawson TM; Ko HS
Neuron; 2021 Dec; 109(23):3758-3774.e11. PubMed ID: 34644545
[TBL] [Abstract][Full Text] [Related]
6. The relationship between glucocerebrosidase mutations and Parkinson disease.
Migdalska-Richards A; Schapira AH
J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):77-90. PubMed ID: 26860875
[TBL] [Abstract][Full Text] [Related]
7. Glucocerebrosidase is imported into mitochondria and preserves complex I integrity and energy metabolism.
Baden P; Perez MJ; Raji H; Bertoli F; Kalb S; Illescas M; Spanos F; Giuliano C; Calogero AM; Oldrati M; Hebestreit H; Cappelletti G; Brockmann K; Gasser T; Schapira AHV; Ugalde C; Deleidi M
Nat Commun; 2023 Apr; 14(1):1930. PubMed ID: 37024507
[TBL] [Abstract][Full Text] [Related]
8. Glucocerebrosidase Mutations Cause Mitochondrial and Lysosomal Dysfunction in Parkinson's Disease: Pathogenesis and Therapeutic Implications.
Zheng W; Fan D
Front Aging Neurosci; 2022; 14():851135. PubMed ID: 35401150
[TBL] [Abstract][Full Text] [Related]
9. Glucocerebrosidase Defects as a Major Risk Factor for Parkinson's Disease.
Avenali M; Blandini F; Cerri S
Front Aging Neurosci; 2020; 12():97. PubMed ID: 32372943
[TBL] [Abstract][Full Text] [Related]
10. Activation and Purification of ß-Glucocerebrosidase by Exploiting its Transporter LIMP-2 - Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease.
Dobert JP; Bub S; Mächtel R; Januliene D; Steger L; Regensburger M; Wilfling S; Chen JX; Dejung M; Plötz S; Hehr U; Moeller A; Arnold P; Zunke F
Adv Sci (Weinh); 2024 Apr; ():e2401641. PubMed ID: 38666485
[TBL] [Abstract][Full Text] [Related]
11. The Role of Cholesterol in α-Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease.
García-Sanz P; M F G Aerts J; Moratalla R
Mov Disord; 2021 May; 36(5):1070-1085. PubMed ID: 33219714
[TBL] [Abstract][Full Text] [Related]
12. Glucocerebrosidase dysfunction in neurodegenerative disease.
Brooker SM; Krainc D
Essays Biochem; 2021 Dec; 65(7):873-883. PubMed ID: 34528667
[TBL] [Abstract][Full Text] [Related]
13. Targeting the GBA1 pathway to slow Parkinson disease: Insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues.
Menozzi E; Toffoli M; Schapira AHV
Pharmacol Ther; 2023 Jun; 246():108419. PubMed ID: 37080432
[TBL] [Abstract][Full Text] [Related]
14. Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function.
Kim MJ; Jeon S; Burbulla LF; Krainc D
Hum Mol Genet; 2018 Jun; 27(11):1972-1988. PubMed ID: 29579237
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease.
Horowitz M; Braunstein H; Zimran A; Revel-Vilk S; Goker-Alpan O
Adv Drug Deliv Rev; 2022 Aug; 187():114402. PubMed ID: 35764179
[TBL] [Abstract][Full Text] [Related]
16. The emerging role of autophagic-lysosomal dysfunction in Gaucher disease and Parkinson's disease.
Kinghorn KJ; Asghari AM; Castillo-Quan JI
Neural Regen Res; 2017 Mar; 12(3):380-384. PubMed ID: 28469644
[TBL] [Abstract][Full Text] [Related]
17. Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model.
Polinski NK; Martinez TN; Gorodinsky A; Gareus R; Sasner M; Herberth M; Switzer R; Ahmad SO; Cosden M; Kandebo M; Drolet RE; Buckett PD; Shan W; Chen Y; Pellegrino LJ; Ellsworth GD; Dungan LB; Hirst WD; Clark SW; Dave KD
PLoS One; 2021; 16(6):e0252325. PubMed ID: 34106956
[TBL] [Abstract][Full Text] [Related]
18. Glucocerebrosidase Mutations and Synucleinopathies. Potential Role of Sterylglucosides and Relevance of Studying Both GBA1 and GBA2 Genes.
Franco R; Sánchez-Arias JA; Navarro G; Lanciego JL
Front Neuroanat; 2018; 12():52. PubMed ID: 30002620
[TBL] [Abstract][Full Text] [Related]
19. A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson's disease.
Burbulla LF; Jeon S; Zheng J; Song P; Silverman RB; Krainc D
Sci Transl Med; 2019 Oct; 11(514):. PubMed ID: 31619543
[TBL] [Abstract][Full Text] [Related]
20. Glucocerebrosidase expression patterns in the non-human primate brain.
Dopeso-Reyes IG; Sucunza D; Rico AJ; Pignataro D; Marín-Ramos D; Roda E; Rodríguez-Pérez AI; Labandeira-García JL; Lanciego JL
Brain Struct Funct; 2018 Jan; 223(1):343-355. PubMed ID: 28835999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
